SCHEMBL2826574

SCHEMBL2826574

Cc1cccc(NC(=O)Oc2ncsc2Nc2ccccc2Br)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.47
HPGD P15428 1/20 0.47
HSD17B10 Q99714 1/20 0.47
GRM5 P41594 5/20 0.42
RAB9A P51151 8/20 0.42
NPC1 O15118 7/20 0.42
KDM4E B2RXH2 1/20 0.42
TSHR P16473 2/20 0.41
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
GBA1 P04062 2/20 0.40
POLB P06746 1/20 0.40
MAPT P10636 2/20 0.39
ATM Q13315 1/20 0.39
LMNA P02545 1/20 0.39
TP53 P04637 1/20 0.39
ALOX15 P16050 1/20 0.39
CASP3 P42574 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2830110 0.89 RAB9A (0.46) ALDH1A1GRM5RAB9ANPC1KDM4E
SCHEMBL2829836 0.88 RAB9A (0.42) GRM5RAB9ANPC1KDM4EKMT2A
SCHEMBL2830797 0.85 RAB9A (0.51) GRM5RAB9ANPC1TSHRKMT2A
SCHEMBL2832205 0.84 RAB9A (0.41) ALDH1A1GRM5RAB9ANPC1KDM4E
SCHEMBL2829349 0.84 NPC1 (0.43) ALDH1A1HPGDGRM5RAB9ANPC1
SCHEMBL2831443 0.82 RAB9A (0.49) ALDH1A1HPGDGRM5RAB9ANPC1
SCHEMBL2830006 0.81 RAB9A (0.44) ALDH1A1GRM5RAB9ANPC1KMT2A
SCHEMBL2827187 0.81 LCK (0.45) ALDH1A1GRM5RAB9ANPC1KMT2A
SCHEMBL2833195 0.81 RAB9A (0.43) GRM5RAB9ANPC1KMT2AMEN1
SCHEMBL2833180 0.80 RAB9A (0.54) GRM5RAB9ANPC1TSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1844044-B1 THIAZOLE-4-CARBOXAMIDE DERIVATIVES AS MGLUR5 ANTAGONISTS HOFFMANN LA ROCHE (CH) 2010-07-21 EP claimed